Health
Biotechnology
Biopharmaceutical
Amarin
$18.779876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$18.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.24 (-1.26%) Today
-$0.24 (-1.26%) Today
Why Robinhood?
You can buy or sell Amarin and other stocks, options, ETFs, and crypto commission-free!
About
Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Read More It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Employees
530
Headquarters
Dublin, Dublin
Founded
1989
Market Cap
6.19B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
8.13M
High Today
$19.10
Low Today
$18.71
Open Price
$19.00
Volume
268.86K
52 Week High
$23.34
52 Week Low
$2.35
Collections
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
Medical
Technology
Therapy
Europe
News
Yahoo Finance12h
APRIL 23 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Amarin Corporation plc – AMRN
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Amarin Corporation plc (AMRN) from September 24, 2018 through November 9, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Amarin investors under the federal securities laws.
Yahoo Finance17h
Class Action AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Update
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
Yahoo FinanceMar 19
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation plc of Class Action Lawsuit and Upcoming Deadline – AMRN
NEW YORK, NY / ACCESSWIRE / March 19, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Amarin Corporation plc (''Amarin'' or the ''Company'') (AMRN) and certain of its officers.
Price Paid on Robinhood
27% Higher
Right Now
52 Week Low
$2.35
Average Price Paid
$14.78
52 Week High
$23.34
Earnings
-$0.10
-$0.08
-$0.06
-$0.04
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 1, Pre-Market